Eli Lilly reported stronger-than-expected fourth-quarter earnings and issued robust guidance for the coming year, as soaring demand for its GLP-1 drugs reaffirmed its dominance in the global weight-loss drugs market. The US pharmaceutical giant posted net income of $6.64 billion, or $7.39 a share, up from $4.41 billion, or $4.88 a share, a year earlier.
US stocks were modestly higher on Monday as investors navigated a mix of political uncertainty, a packed earnings calendar and anticipation ahead of the Federal Reserve’s first policy decision of the year. The S&P 500 edged up 0.2%, while the Dow Jones Industrial Average gained 170 points, or 0.4%. The Nasdaq Composite hovered around the
US stocks were mixed on Tuesday as gains in large technology companies lifted the broader market, while sharp losses in health insurers weighed heavily on the Dow Jones Industrial Average. Investors also positioned cautiously ahead of a heavy slate of corporate earnings and the Federal Reserve’s first policy decision of the year, due on Wednesday.
US equities advanced on Wednesday, with the S&P 500 reaching the 7,000 level for the first time, as investors positioned ahead of the Federal Reserve’s interest rate decision and a slate of earnings reports from major technology companies. The benchmark index rose 0.3% and touched an intraday high of 7,002.28, marking a symbolic milestone for
US stocks were mixed on Thursday as investors balanced a fresh wave of earnings from major technology companies against the Federal Reserve’s latest interest rate decision and lingering political and geopolitical uncertainty. The S&P 500 edged up 0.1%, reflecting a cautious tone after the benchmark briefly crossed the 7,000 level in the prior session. The
US stocks edged lower on Monday as Wall Street kicked off a new month of trading under renewed pressure from technology shares and sharp swings in cryptocurrencies and precious metals. The S&P 500 was last down 0.3%, moving in tandem with the Nasdaq Composite. The Dow Jones Industrial Average fell 143 points, or 0.3%, as
Ripple has secured full approval for an Electronic Money Institution licence in Luxembourg, a regulatory milestone that clears the way for the company to scale payments services across the European Union. The authorisation was granted by Luxembourg’s financial regulator, the Commission de Surveillance du Secteur Financier, after Ripple met all outstanding conditions tied to its
Solana’s SOL has been one of the worst performers among the top 10 cryptocurrencies by market cap in recent weeks. The coin temporarily dropped below the $100 psychological level after losing more than 15% in the previous week. SOL’s bearish price action is further backed by derivatives data, which shows rising short bets and negative
The S&P 500 Index and its ETFs, like SPY, IVV, and VOO, remained in a tight range close to the all-time high after key earnings from some of the biggest American companies last week. They also wavered after Donald Trump announced his nominee for the Federal Reserve on Friday. This article looks at some of
Walt Disney Co. shares rose in early trading on Monday after the media giant reported fiscal first-quarter results that exceeded Wall Street expectations, supported by strong performance in streaming and continued momentum at its theme parks, resorts, and cruise businesses. The company posted adjusted earnings of $1.63 a share for the quarter ended Dec. 27,